Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hyperactivity disorder (ADHD) therapy for approval in Japan.The game-based digital therapeutic (DTx) has been filed for approval with Japan’s Ministry of Health, Labour, and Welfare (MHLW) as […]

Author